Henry M. Jackson Foundation for the Advancement of Military Medicine

Advancing Military Medicine

Search Results - geeta+upadhyay

2 Results Sort By:
Lymphocyte Antigen 6 (Ly6) Targeted Cancer Immunotherapy (HJF 649-23)
A technology related to using antibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) transduced immune cells that selectively targets Ly6 family of proteins overexpressed in cancer cells and has the potential to be effective in treating ovarian, colorectal, gastric, breast, and lung cancer without off-target effects. This HJF technology...
Published: 12/12/2024   |   Updated: 5/3/2024   |   Inventor(s): Geeta Upadhyay
Keywords(s): Antibody, Antibody Conjugates, Antibody Drug Conjugate, Cancer, CAR, Ly6, Lymphocite Antigen 6
Category(s): Therapeutic
Small Molecule Targeted Therapeutics for Breast Cancer - (HJF 533-19)
A technology related to using novel small molecule therapeutics for breast cancer treatment is available for licensing from HJF. These small molecules specifically inhibit LY6K, a cancer-testis oncoprotein, in cancer cells, thus providing a novel targeted therapy for breast, colorectal, and other cancers. Applications and Advantages Targeted therapeutics...
Published: 10/17/2024   |   Updated: 1/23/2023   |   Inventor(s): Geeta Upadhyay
Keywords(s): Breast Cancer, Cancer, Colorectal Cancer, LY6K, Oncogene, Small Molecule, Therapeutics
Category(s): Therapeutic